Raised antibody levels linked to greater long term risk of rheumatoid arthritis
Individuals with raised levels of an antibody known as rheumatoid factor in their blood have up to a 26-fold greater long term risk of developing rheumatoid arthritis, finds a study published in British Medical Journal today.
These findings suggest the need for early referral for examination after a positive rheumatoid factor test – even in the absence of typical arthritic symptoms like pain and swelling in the joints, say the authors.
Rheumatoid arthritis is a chronic inflammatory joint disorder that affects around 1 per cent of the world's population – women three times more often than men.
No blood test can definitively diagnose rheumatoid arthritis, but a positive rheumatoid factor test can indicate the condition. However, it is not clear whether high levels of this antibody in people without rheumatoid arthritis is associated with later development of the condition
So a team of researchers based at University of Copenhagen and Copenhagen University Hospital set out to test whether raised levels of rheumatoid factor is associated with long term development of rheumatoid arthritis.
9,712 Danes involved in study
They measured rheumatoid factor levels in 9,712 white Danish individuals aged 20 to 100 years without rheumatoid arthritis at the start of the study and followed them for up to 28 years.
Raised rheumatoid factor levels of 25-50 IU/mL, 50.1-100 IU/mL and more than 100 IU/mL were compared with normal levels (less than 25 IU/mL).
During the study period, 183 individuals developed rheumatoid arthritis.
After taking account of several other possible risk factors, a doubling of rheumatoid factor level was associated with a 3.3-fold increased risk of developing rheumatoid arthritis. The highest rheumatoid factor level (100 IU/mL or more) was associated with a 26-fold increased risk of developing the condition.
Highest risk seen in 50-69 year old women
In absolute terms, the highest 10 year risk of rheumatoid arthritis of 32 per cent was seen in 50-69 year old women who smoked and had rheumatoid factor levels of 100 IU/mL or more.
The lowest absolute 10 year risk of rheumatoid arthritis of 0.1 per cent was seen in men aged 70 years and over with rheumatoid factor levels of less than 25 IU/mL.
The authors stress that their study cannot prove that rheumatoid factor plays a causal role in the development of rheumatoid arthritis, but they conclude that the findings “may lead to revision of guidelines for early referral to a rheumatologist and early arthritis clinics based on a positive rheumatoid factor test – even in the absence of the typical arthritic joint symptoms.”
Read the article in British Medical Journal here
Professor Børge Nordestgaard,
Tel: +45 30 28 72 63